TABLE 3.
Men |
Women |
|||||||||
Model 1 |
Model 2 |
Model 1 |
Model 2 |
|||||||
IQR (%) | Cohort, n | Cases, n | HR (95% CI) | HR (95% CI) | IQR (%) | Cohort, n | Cases, n | HR (95% CI) | HR (95% CI) | |
SFA | ||||||||||
Tertile 1 | 44.0–44.7 | 140 | 66 | 1.00 | 1.00 | 44.3–45.0 | 168 | 103 | 1.00 | 1.00 |
Tertile 2 | 45.2–45.5 | 153 | 53 | 0.71 (0.49, 1.02) | 0.71 (0.49, 1.04) | 45.4–45.7 | 150 | 122 | 1.12 (0.86, 1.46) | 1.19 (0.91, 1.55) |
Tertile 3 | 46.0–46.5 | 136 | 70 | 1.03 (0.73, 1.44) | 1.10 (0.77, 1.56) | 46.1–46.7 | 151 | 121 | 1.15 (0.89, 1.50) | 1.22 (0.94, 1.59) |
P-trend | — | — | — | 0.85 | 0.56 | — | — | — | 0.29 | 0.15 |
MUFA | ||||||||||
Tertile 1 | 13.1–14.2 | 160 | 46 | 1.00 | 1.00 | 13.4–14.4 | 164 | 107 | 1.00 | 1.00 |
Tertile 2 | 14.9–15.5 | 148 | 58 | 1.18 (0.80, 1.75) | 1.15 (0.77, 1.72) | 15.0–15.6 | 155 | 117 | 1.14 (0.88, 1.49) | 1.17 (0.90, 1.52) |
Tertile 3 | 16.3–17.6 | 121 | 85 | 1.62 (1.12, 2.34) | 1.60 (1.09, 2.33) | 16.3–17.6 | 150 | 122 | 1.10 (0.84, 1.43) | 1.13 (0.86, 1.49) |
P-trend | — | — | — | 0.008 | 0.01 | — | — | — | 0.51 | 0.37 |
PUFA | ||||||||||
Tertile 1 | 36.2–37.5 | 123 | 83 | 1.00 | 1.00 | 35.8–37.3 | 146 | 125 | 1.00 | 1.00 |
Tertile 2 | 38.3–38.8 | 145 | 61 | 0.79 (0.57, 1.11) | 0.82 (0.58, 1.16) | 38.0–38.6 | 147 | 125 | 1.09 (0.85, 1.40) | 1.10 (0.85, 1.42) |
Tertile 3 | 39.6–40.5 | 161 | 45 | 0.62 (0.43, 0.91) | 0.60 (0.41, 0.89) | 39.1–40.2 | 176 | 96 | 0.78 (0.59, 1.02) | 0.76 (0.58, 1.00) |
P-trend | — | — | — | 0.01 | 0.01 | — | — | — | 0.08 | 0.06 |
n–6 | ||||||||||
Tertile 1 | 22.4–25.5 | 144 | 62 | 1.00 | 1.00 | 23.0–26.0 | 160 | 111 | 1.00 | 1.00 |
Tertile 2 | 27.5–28.8 | 133 | 73 | 1.32 (0.94, 1.86) | 1.30 (0.92, 1.85) | 27.8–29.2 | 132 | 140 | 1.34 (1.04, 1.72) | 1.43 (1.10, 1.85) |
Tertile 3 | 30.2–32.1 | 152 | 54 | 1.01 (0.70, 1.47) | 0.97 (0.67, 1.42) | 30.3–31.9 | 177 | 95 | 0.86 (0.65, 1.15) | 0.91 (0.68, 1.21) |
P-trend | — | — | — | 0.92 | 0.91 | — | — | — | 0.36 | 0.56 |
n–3 | ||||||||||
Tertile 1 | 7.11–8.42 | 134 | 72 | 1.00 | 1.00 | 6.87–8.14 | 162 | 109 | 1.00 | 1.00 |
Tertile 2 | 9.78–11.2 | 141 | 65 | 0.89 (0.64, 1.25) | 0.92 (0.65, 1.29) | 9.12–10.3 | 146 | 126 | 1.16 (0.90, 1.51) | 1.17 (0.90, 1.53) |
Tertile 3 | 12.8–15.5 | 154 | 52 | 0.61 (0.43, 0.88) | 0.66 (0.45, 0.95) | 12.1–15.0 | 161 | 111 | 0.98 (0.75, 1.28) | 0.93 (0.71, 1.23) |
P-trend | — | — | — | 0.009 | 0.03 | — | — | — | 0.87 | 0.60 |
n–6:n–3 ratio | ||||||||||
Tertile 1 | 1.45–2.00 | 148 | 58 | 1.00 | 1.00 | 1.55–2.19 | 156 | 115 | 1.00 | 1.00 |
Tertile 2 | 2.44–2.93 | 143 | 63 | 1.27 (0.88, 1.82) | 1.22 (0.85, 1.76) | 2.73–3.20 | 146 | 126 | 1.10 (0.85, 1.42) | 1.15 (0.89, 1.49) |
Tertile 3 | 3.57–4.48 | 138 | 68 | 1.39 (0.97, 1.99) | 1.32 (0.92, 1.90) | 3.68–4.49 | 167 | 105 | 0.94 (0.71, 1.23) | 0.99 (0.75, 1.30) |
P-trend | — | — | — | 0.07 | 0.14 | — | — | — | 0.66 | 0.95 |
LA | ||||||||||
Tertile 1 | 13.6–15.7 | 140 | 66 | 1.00 | 1.00 | 13.7–15.9 | 155 | 116 | 1.00 | 1.00 |
Tertile 2 | 16.8–18.1 | 145 | 61 | 0.83 (0.59, 1.19) | 0.83 (0.58, 1.19) | 17.3–18.3 | 155 | 117 | 1.08 (0.83, 1.40) | 1.10 (0.85, 1.43) |
Tertile 3 | 19.5–21.5 | 144 | 62 | 0.97 (0.68, 1.38) | 0.91 (0.63, 1.31) | 19.5–21.0 | 159 | 113 | 0.99 (0.76, 1.29) | 1.02 (0.78, 1.33) |
P-trend | — | — | — | 0.83 | 0.58 | — | — | — | 0.96 | 0.90 |
AA | ||||||||||
Tertile 1 | 5.03–5.84 | 142 | 64 | 1.00 | 1.00 | 5.03–5.72 | 163 | 108 | 1.00 | 1.00 |
Tertile 2 | 6.37–7.12 | 143 | 63 | 1.25 (0.87, 1.78) | 1.25 (0.87, 1.80) | 6.39–7.02 | 145 | 127 | 1.41 (1.09, 1.83) | 1.42 (1.09, 1.85) |
Tertile 3 | 7.76–9.24 | 144 | 62 | 1.26 (0.87, 1.81) | 1.26 (0.87, 1.84) | 7.76–9.19 | 161 | 111 | 1.17 (0.89, 1.54) | 1.24 (0.94, 1.64) |
P-trend | — | — | — | 0.22 | 0.22 | — | — | — | 0.25 | 0.12 |
ALA | ||||||||||
Tertile 1 | 0.14–0.17 | 145 | 61 | 1.00 | 1.00 | 0.14–0.17 | 157 | 114 | 1.00 | 1.00 |
Tertile 2 | 0.19–0.22 | 146 | 60 | 0.89 (0.63, 1.28) | 0.86 (0.60, 1.24) | 0.20–0.22 | 148 | 124 | 1.15 (0.89, 1.49) | 1.16 (0.90, 1.51) |
Tertile 3 | 0.26–0.34 | 138 | 68 | 1.04 (0.73, 1.48) | 0.99 (0.70, 1.42) | 0.26–0.33 | 164 | 108 | 0.93 (0.71, 1.21) | 0.91 (0.70, 1.19) |
P-trend | — | — | — | 0.81 | 1.00 | — | — | — | 0.59 | 0.50 |
EPA | ||||||||||
Tertile 1 | 1.27–1.71 | 128 | 78 | 1.00 | 1.00 | 1.20–1.63 | 160 | 111 | 1.00 | 1.00 |
Tertile 2 | 2.23–2.96 | 144 | 62 | 0.81 (0.58, 1.14) | 0.81 (0.57, 1.14) | 2.04–2.52 | 145 | 127 | 1.19 (0.92, 1.55) | 1.24 (0.95, 1.60) |
Tertile 3 | 3.97–5.46 | 157 | 49 | 0.55 (0.39, 0.80) | 0.59 (0.41, 0.86) | 3.40–5.24 | 164 | 108 | 0.97 (0.74, 1.27) | 0.96 (0.73, 1.26) |
P-trend | — | — | — | 0.001 | 0.005 | — | — | — | 0.82 | 0.77 |
DHA | ||||||||||
Tertile 1 | 4.48–5.24 | 136 | 70 | 1.00 | 1.00 | 4.32–5.10 | 164 | 107 | 1.00 | 1.00 |
Tertile 2 | 6.02–6.83 | 146 | 60 | 0.75 (0.53, 1.06) | 0.78 (0.54, 1.11) | 5.74–6.33 | 146 | 126 | 1.28 (0.99, 1.66) | 1.28 (0.98, 1.66) |
Tertile 3 | 7.50–8.60 | 147 | 59 | 0.75 (0.53, 1.06) | 0.80 (0.56, 1.14) | 7.12–8.48 | 159 | 113 | 1.04 (0.79, 1.36) | 1.28 (0.98, 1.66) |
P-trend | — | — | — | 0.10 | 0.21 | — | — | — | 0.80 | 0.92 |
DPA | ||||||||||
Tertile 1 | 0.94–1.05 | 140 | 66 | 1.00 | 1.00 | 0.87–0.99 | 158 | 113 | 1.00 | 1.00 |
Tertile 2 | 1.14–1.22 | 148 | 58 | 0.74 (0.52, 1.06) | 0.75 (0.52, 1.08) | 1.07–1.15 | 151 | 121 | 1.03 (0.79, 1.33) | 1.01 (0.78, 1.31) |
Tertile 3 | 1.30–1.49 | 140 | 66 | 0.83 (0.59, 1.18) | 0.87 (0.61, 1.24) | 1.24–1.39 | 160 | 112 | 0.97 (0.74, 1.26) | 0.91 (0.70, 1.20) |
P-trend | — | — | — | 0.33 | 0.48 | — | — | — | 0.82 | 0.51 |
Associations were tested by using multivariate Cox hazard models. Model 1 was adjusted for age at the AGES-Reykjavik Study baseline and education. Model 2 was adjusted as for model 1 and for smoking status, height, weight, prevalent diabetes, physical activity, and estrogen and glucocorticoid use. Tests for trend were performed by assigning the median value to each tertile and modeling this as a continuous variable. AA, arachidonic acid; AGES-Reykjavik, Age, Gene/Environment Susceptibility Study; ALA, α-linolenic acid; DPA, docosapentaenoic acid; LA, linoleic acid.